Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0001193125-13-095884
Filing Date
2013-03-07
Accepted
2013-03-07 15:32:06
Documents
12
Period of Report
2013-03-07

Document Format Files

Seq Description Document Type Size
1 6-K d497338d6k.htm 6-K 10448
2 EX-99.1 d497338dex991.htm EX-99.1 52053
3 GRAPHIC g497338ex99_1s10gbgd.jpg GRAPHIC 21046
4 GRAPHIC g497338ex99_1s1gbgd.jpg GRAPHIC 23287
5 GRAPHIC g497338ex99_1s2gbgd.jpg GRAPHIC 18190
6 GRAPHIC g497338ex99_1s3gbgd.jpg GRAPHIC 39075
7 GRAPHIC g497338ex99_1s4gbgd.jpg GRAPHIC 19585
8 GRAPHIC g497338ex99_1s5gbgd.jpg GRAPHIC 19968
9 GRAPHIC g497338ex99_1s6gbgd.jpg GRAPHIC 19968
10 GRAPHIC g497338ex99_1s7gbgd.jpg GRAPHIC 19968
11 GRAPHIC g497338ex99_1s8gbgd.jpg GRAPHIC 19770
12 GRAPHIC g497338ex99_1s9gbgd.jpg GRAPHIC 34223
  Complete submission text file 0001193125-13-095884.txt   388962
Mailing Address LEVEL 7, 151 MACQUARIE STREET SYDNEY, NEW SOUTH WALES C3 2000
Business Address LEVEL 7, 151 MACQUARIE STREET SYDNEY, NEW SOUTH WALES C3 2000 612 9276 1224
Prima BioMed Ltd (Filer) CIK: 0001506184 (see all company filings)

EIN.: 000000000
Type: 6-K | Act: 34 | File No.: 001-35428 | Film No.: 13673244
SIC: 2834 Pharmaceutical Preparations